-
1
-
-
33744968835
-
Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: The National Health and Nutrition Examination Survey
-
HE Resnick GL Foster J Bardsley RE Ratner 2006 Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, 1999-2002. The National Health and Nutrition Examination Survey Diabetes Care 29 531 537 16505501 10.2337/diacare.29.03.06.dc05-1254 (Pubitemid 44115349)
-
(2006)
Diabetes Care
, vol.29
, Issue.3
, pp. 531-537
-
-
Resnick, H.E.1
Foster, G.L.2
Bardsley, J.3
Ratner, R.E.4
-
2
-
-
0036315193
-
Evaluation of risk factors for development of complications in Type II diabetes in Europe
-
ODE-2 Advisory Board. 12136408 10.1007/s00125-002-0874-x 1:CAS:528:DC%2BD38XltlOnt7g%3D
-
A Liebl M Mata E Eschwège ODE-2 Advisory Board 2002 Evaluation of risk factors for development of complications in Type II diabetes in Europe Diabetologia 45 S23 S28 12136408 10.1007/s00125-002-0874-x 1:CAS:528: DC%2BD38XltlOnt7g%3D
-
(2002)
Diabetologia
, vol.45
-
-
Liebl, A.1
Mata, M.2
Eschwège, E.3
-
3
-
-
3042714557
-
The burden of treatment failure in type 2 diabetes
-
DOI 10.2337/diacare.27.7.1535
-
JB Brown GA Nichols A Perry 2004 The burden of treatment failure in type 2 diabetes Diabetes Care 27 1535 1540 15220224 10.2337/diacare.27.7.1535 (Pubitemid 38857422)
-
(2004)
Diabetes Care
, vol.27
, Issue.7
, pp. 1535-1540
-
-
Brown, J.B.1
Nichols, G.A.2
Perry, A.3
-
5
-
-
43449100355
-
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study
-
18435671 10.1111/j.1463-1326.2008.00882.x
-
F Alvarez Guisasola S Tofé Povedano G Krishnarajah R Lyu P Mavros D Yin 2008 Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study Diabetes Obes Metab 10 Suppl 1 25 32 18435671 10.1111/j.1463-1326.2008.00882.x
-
(2008)
Diabetes Obes Metab
, vol.10
, Issue.SUPPL. 1
, pp. 25-32
-
-
Alvarez Guisasola, F.1
Tofé Povedano, S.2
Krishnarajah, G.3
Lyu, R.4
Mavros, P.5
Yin, D.6
-
6
-
-
34250636401
-
Antidiabetic medications in overweight/obese patients with type 2 diabetes: Drawbacks of current drugs and potential advantages of incretin-based treatment on body weight
-
DOI 10.1111/j.1742-1241.2007.01441.x
-
E Bonora 2007 Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight Int J Clin Pract Suppl 154 19 28 17593274 10.1111/j.1742-1241.2007.01441.x 1:CAS:528:DC%2BD2sXpvFSnt70%3D (Pubitemid 46934643)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.SUPPL. 154
, pp. 19-28
-
-
Bonora, E.1
-
7
-
-
79955800879
-
International Diabetes Federation Clinical Guidelines Task Force
-
International Diabetes Federation Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. 2005. www.idf.org
-
(2005)
Global Guideline for Type 2 Diabetes
-
-
-
8
-
-
63149173251
-
Standards of Medical Care in Diabetes - 2009
-
American Diabetes Association. 10.2337/dc09-S013
-
American Diabetes Association 2009 Standards of Medical Care in Diabetes - 2009 Diabetes Care 32 Suppl. 1 S13 S61 10.2337/dc09-S013
-
(2009)
Diabetes Care
, vol.32
, Issue.SUPPL. 1
-
-
-
9
-
-
75449119649
-
Antidiabetische Therapie bei Typ-2 Diabetes
-
M Clodi P Fasching F Hoppichler A Kautzky-Willer M Lechleitner B Ludvik R Prager M Roden G Schernthaner H Toplak TC Wascher R Weitgasser 2009 Antidiabetische Therapie bei Typ-2 Diabetes Wien Klin Wochenschr 121 Suppl. 5 S13 S17
-
(2009)
Wien Klin Wochenschr
, vol.121
, Issue.SUPPL. 5
-
-
Clodi, M.1
Fasching, P.2
Hoppichler, F.3
Kautzky-Willer, A.4
Lechleitner, M.5
Ludvik, B.6
Prager, R.7
Roden, M.8
Schernthaner, G.9
Toplak, H.10
Wascher, T.C.11
Weitgasser, R.12
-
10
-
-
33845998516
-
The role of gut hormones in glucose homeostasis
-
DOI 10.1172/JCI30076
-
DJ Drucker 2007 The role of gut hormones in glucose homeostasis J Clin Invest 117 24 32 17200703 10.1172/JCI30076 1:CAS:528:DC%2BD2sXmvV2rsw%3D%3D (Pubitemid 46048446)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.1
, pp. 24-32
-
-
Drucker, D.J.1
-
11
-
-
33845476757
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
-
DOI 10.2337/dc06-0706
-
B Charbonnel A Karasik J Liu M Wu G Meininger Sitagliptin Study 020 Group 2006 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone Diabetes Care 29 2638 2643 17130197 10.2337/dc06-0706 1:CAS:528:DC%2BD2sXhtVGhtQ%3D%3D (Pubitemid 44912191)
-
(2006)
Diabetes Care
, vol.29
, Issue.12
, pp. 2638-2643
-
-
Charbonnel, B.1
Karasik, A.2
Liu, J.3
Wu, M.4
Meininger, G.5
-
12
-
-
33846817233
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial
-
DOI 10.1111/j.1463-1326.2006.00704.x, Future Treatments: A Focus on Dipeptidyl Peptidase-IV Inhibitors
-
MA Nauck G Meininger D Sheng L Terranella PP Stein Sitagliptin Study 024 Group 2007 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial Diabetes Obes Metab 9 194 205 17300595 10.1111/j.1463-1326.2006.00704.x 1:CAS:528:DC%2BD2sXjs1SrtLw%3D (Pubitemid 46206563)
-
(2007)
Diabetes, Obesity and Metabolism
, vol.9
, Issue.2
, pp. 194-205
-
-
Nauck, M.A.1
Meininger, G.2
Sheng, D.3
Terranella, L.4
Stein, P.P.5
Tesone, P.6
Davis, T.7
Colagiuri, S.8
Prager, R.9
Schernthaner, G.10
Toplak, H.11
Wascher, T.12
Coucke, F.13
De Meulemeester, M.14
Ducobu, J.15
Gross, J.16
Zanella, M.T.17
Godoy, G.18
Hernandez, E.19
Profozic, V.20
Kvapil, M.21
Tomas, B.22
Umlauf, P.23
Zemanova, J.24
Egstrup, K.25
Hansen, A.26
Hermansen, K.27
Eriksson, J.28
Lahtela, J.29
Niskanen, L.30
Salmela, P.31
Bauduceau, B.32
Bringer, J.33
Charpentier, G.34
Krempf, M.35
Marre, M.36
Weryha, G.37
Adler, J.38
Bouzo, H.39
Derwahl, K.M.40
Hanefeld, M.41
Kirchberg, H.G.42
Klausmann, G.43
Klein, C.44
Lehmann, R.45
Nauck, M.46
Oerter, E.47
Schulze, E.D.48
Weisbrod, A.49
Weyland, K.50
Zoller, T.51
Lam, K.52
Vadasz, J.53
Vandorfi, G.54
Baule, G.55
DeMattia, G.56
Gambardella, S.57
Ghirlanda, G.58
Lauro, R.59
Squatrito, S.60
Zabuliene, L.61
Chan, S.62
Mohamed, M.63
Sauque, L.64
De Backer, W.A.65
Wins, E.H.R.66
Benatar, J.67
Scott, R.68
Cooper, J.69
Furuseth, K.70
Kulseng, B.71
Molina, G.72
Rodriguez, A.73
Pacheco, E.74
Markiewicz, K.75
Pinis, G.76
Raposo, J.77
Teles, G.78
Eng, P.79
Burgess, L.80
Moore, R.81
Wing, J.82
Calle-Pascual, A.83
Garcia, S.D.84
Roca, F.V.85
Pino, J.L.86
Puig, J.M.87
Eizyk, E.88
Frid, A.89
Lagerback, P.A.90
Smith, U.91
Edde, M.92
Saner, H.93
Chang, C.J.94
Hwu, C.M.95
Tu, S.T.96
Demirtunc, R.97
Satman, I.98
Haworth, D.99
more..
-
13
-
-
34249853401
-
Review of sitagliptin phosphate: A novel treatment for type 2 diabetes
-
DOI 10.2147/vhrm.2007.3.2.203
-
B Gallwitz 2007 Review of sitagliptin phosphate: a novel treatment for type 2 diabetes Vasc Health Risk Manag 3 203 210 17580730 10.2147/vhrm.2007.3.2. 203 1:CAS:528:DC%2BD2sXntFOmt74%3D (Pubitemid 46860709)
-
(2007)
Vascular Health and Risk Management
, vol.3
, Issue.2
, pp. 203-210
-
-
Gallwitz, B.1
-
14
-
-
79955870668
-
Treatment of type 2 diabetes mellitus (T2DM) with Sitagliptin - Efficacy and safety in a real-life setting
-
K Kusterer HJ Rümann C Hens 2009 Treatment of type 2 diabetes mellitus (T2DM) with Sitagliptin - efficacy and safety in a real-life setting Br J Clin Pharmacol 68 Suppl. 1 52
-
(2009)
Br J Clin Pharmacol
, vol.68
, Issue.SUPPL. 1
, pp. 52
-
-
Kusterer, K.1
Rümann, H.J.2
Hens, C.3
-
15
-
-
0037126526
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421
-
(2002)
Circulation
, vol.106
, pp. 3143-421
-
-
-
16
-
-
65449133147
-
Metformin - The gold standard in type 2 diabetes: What does the evidence tell us?
-
19385978 10.1111/j.1463-1326.2008.01031.x 1:CAS:528:DC%2BD1MXlvFOiur0%3D
-
E Bosi 2009 Metformin - the gold standard in type 2 diabetes: what does the evidence tell us? Diabetes Obes Metab 11 Suppl. 2 3 8 19385978 10.1111/j.1463-1326.2008.01031.x 1:CAS:528:DC%2BD1MXlvFOiur0%3D
-
(2009)
Diabetes Obes Metab
, vol.11
, Issue.SUPPL. 2
, pp. 3-8
-
-
Bosi, E.1
|